Host immune biomarkers associated with infection risk after CAR T-cell therapy. (PubMed, J Infect) - Sep 24, 2026 - "Longitudinal immune profiling identified distinct immunological signatures linked to infection risk and CAR-T-related toxicities. These findings suggest a role for immune monitoring in improving risk stratification and guiding supportive care after CAR-T therapy."
Biomarker • IO biomarker • Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Infectious Disease • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • IL12A • RNASE1 • TNFA
|
|
Adrian Minson; Alex Garnham; Benjamin W Teh; Gemma K Reynolds; Goknur Giner; Jane Oliaro; Karin Thursky; Lewis Williams; Lynette Chee; Marcel Doerflinger; Mark R Dowling; Mary Ann Anderson; Michael Dickinson; Monica A Slavin; Simon J Harrison; Therease Jansen
|